Search This Blog

Wednesday, July 1, 2026

Baird initiates Abbott Laboratories at Outperform with $121 price target

 


  • Baird cites Abbott's diversified portfolio and product pipeline as supporting sustained revenue and earnings growth.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)